军事知识服务平台
H221Y突变在HIV-1B '亚型毒株中的流行状况及突变模式
Prevalence status and mutation pattern of H221Y in subtype B' of HIV-1
摘要 目的 探讨人类免疫缺陷病毒( HIV)逆转录酶区H221Y突变在抗病毒治疗失败人群HIV-1B’亚型毒株中的流行状况及突变模式.方法 提取我国中部地区多个省份1205例抗病毒治疗失败及158例未抗病毒治疗的艾滋病患者血浆样本RNA,扩增HIV B’亚型毒株聚合酶区(pol区)基因序列提交斯坦福大学HIV-1耐药数据库,根据数据库比对结果,分析H221Y突变在2组人群中发生频率及发生模式.结果 H221Y突变在抗病毒治疗失败人群中流行率(6.59%)显著高于未治疗人群(0.60%)(x2=6.59,P=0.027).该突变的发生常伴随逆转录酶区位点T215、M184、K103、Y181突变的出现,突变模式以TAMs/H221 Y/Y181C/I为主.5种抗病毒治疗方案中,齐多夫定(AZT)/去羟肌苷(ddI)/奈韦拉平(NVP)治疗方案的H221Y突变发生率显著高于其他4种治疗方案(14.6%比3.5%、4.9%、2.3%、2.6%,均P <0.01).结论 使用一线方案治疗失败的艾滋病患者中H221Y突变有一定流行,该突变的发生以特有的突变模式出现.
Abstract:
Objective To explore the prevalence and mutation pattern of H221Y at reverse transcriptase (RT) among the subtype B' of human immunodeficiency virusl ( HIV-1 ) in antiviral therapyfailure patients.Methods A total of 1363 sequences,comprising of 1205 therapy-failure individuals and 158 therapy-naive individuals,were submitted to the Stanford HIV drug resistance database (SHDB) to analyze the frequency and mutation pattern of H221Y.Results The prevalence of mutation H221Y in the therapy-failure population was significantly higher than that of the therapy-naive (6.59% vs 0.60% ) ( x2 =6.59,P =0.027).The emergence of H221Y usually accompanied the position mutations of T215,M184,K103 and Y181 of RT,and the pattern of TAMs/H221Y/Y181C/I was common.Frequency of H221Y in the regimen of AZT/ddI/NVP was more popular than the other 4 regimens ( 14.6% vs 3.5%,4.9%,2.3%,2.6%,all P <0.01 ).Conclusion With a unique mutation pattern,H221Y has a low prevalence in the individuals of first-line therapy-failure patients.
Author: LI Han-ping GUO Wei LIU Yong-jian BAO Zuo-yi LI Lin ZHUANG Dao-min LIU Si-yang WANG Xiao-lin LI Jing-yun
作者单位: 军事医学科学院微生物流行病研究所病原微生物生物安全国家重点实验室,北京,100071
刊 名 中华医学杂志 ISTICPKU
年,卷(期): 2012, 92(4)
分类号: R4
机标分类号: R512.91 R683.42 R3
在线出版日期: 2012年3月20日
基金项目: 30830088:国家自然科学基金2008ZX10001-004:国家科技重大专项,